OncoPrecision Employee Directory
Biotechnology ResearchNew York, United States11-50 Employees
OncoPrecision is a biotechnology research company located at 7 Pennsylvania Plaza Floor 9 in New York, New York, United States, with 11-50 employees. It focuses on precision oncology, engineering first-in-class antibody-drug conjugates and bispecific antibodies to treat hard-to-treat cancers. The company combines Patient Micro-Avatars with AI-driven target validation across billions of phenotypic data points to surface biology that may be missed by population-level datasets. Its lead program, ONC001, is a first-in-class CD64-targeting ADC designed to eliminate leukemic monocytes and tumor-associated macrophages and is advancing through IND-enabling studies. Public disclosures include seed financing rounds in 2022 and participation in industry events such as the ASH Annual Meeting.